Telmisartan attenuates fatty-acid-induced oxidative stress and NAD(P)H oxidase activity in pancreatic β-cells
Authors:
- W. HongweiWHW. Hongwei
- H. UenoHUH. Ueno
- M. MizutaMMM. Mizuta
- M. NakazatoMNM. Nakazato
- 1 November 2009
- journal article
- Published by Elsevier in Diabetes & Metabolism
- Vol. 35 (5) , 392-397
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonistBiochemical and Biophysical Research Communications, 2005
- Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndromeCardiovascular Diabetology, 2005
- Pancreatic Islet Renin Angiotensin SystemPancreas, 2005
- Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating ActivityHypertension, 2004
- Local renin–angiotensin systems: the unanswered questionsThe International Journal of Biochemistry & Cell Biology, 2003
- Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover.Diabetes, 2001
- The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCPBiochemical Journal, 2000
- The tissue renin-angiotensin system in human pancreasJournal of Endocrinology, 1999
- Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemiaNature Genetics, 1997
- Palmitate-induced beta-cell insensitivity to glucose is coupled to decreased pyruvate dehydrogenase activity and enhanced kinase activity in rat pancreatic isletsDiabetes, 1995